We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Sempra
SRE
$58.1B
| $3.29M | 0.05% |
59,050
-394,320
| -87% | -$21.5M |
|
327
Innoviva
INVA
$1.6B
| $3.29M | 0.05% |
232,282
+153,248
| +194% | +$2.3M |
|
328
iShares MSCI Turkey ETF
TUR
$201M
| $3.26M | 0.05% |
+60,000
| New | +$3.18M |
|
|
NSR
329
PUT
DELISTED
Neustar Inc
NSR
| $3.24M | 0.05% |
116,600
+116,188
| +28,201% | +$3.05M |
|
|
SCHW
330
Charles Schwab
SCHW
$182B
| $3.21M | 0.05% |
106,151
-31,452
| -23% | -$894K |
|
331
Melco Resorts & Entertainment
MLCO
$2.21B
| $3.21M | 0.05% |
+126,133
| New | +$3.16M |
|
332
Dollar General
DG
$28.4B
| $3.17M | 0.04% |
44,805
-10,929
| -20% | -$711K |
|
|
WCC
333
WESCO International
WCC
$15.1B
| $3.17M | 0.04% |
41,541
-19,321
| -32% | -$1.52M |
|
334
Travere Therapeutics
TVTX
$5.17B
| $3.14M | 0.04% |
256,408
+7,316
| +3% | +$75.7K |
|
|
MHFI
335
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $3.06M | 0.04% |
34,394
+2,295
| +7% | +$202K |
|
336
Canadian Solar
CSIQ
$932M
| $3.04M | 0.04% |
+125,800
| New | +$3.42M |
|
337
Liberty Broadband Class A
LBRDA
$4.89B
| $3.04M | 0.04% |
+60,663
| New | +$3M |
|
|
ISBC
338
DELISTED
Investors Bancorp, Inc.
ISBC
| $3.04M | 0.04% |
+270,677
| New | +$2.88M |
|
|
TLM
339
DELISTED
TALISMAN ENERGY INC
TLM
| $3.04M | 0.04% |
387,429
-870,581
| -69% | -$5.47M |
|
|
SEE
340
DELISTED
Sealed Air
SEE
| $3.03M | 0.04% |
71,462
+65,517
| +1,102% | +$2.46M |
|
|
AMRN
341
Amarin Corp
AMRN
$297M
| $2.94M | 0.04% |
150,000
| – | – |
|
342
Progressive
PGR
$128B
| $2.93M | 0.04% |
+108,555
| New | +$2.86M |
|
343
Dine Brands
DIN
$462M
| $2.91M | 0.04% |
+28,035
| New | +$2.59M |
|
|
PL
344
DELISTED
PROTECTIVE LIFE CORP
PL
| $2.82M | 0.04% |
+40,502
| New | +$2.82M |
|
|
BMS
345
DELISTED
Bemis
BMS
| $2.82M | 0.04% |
62,333
+53,135
| +578% | +$2.14M |
|
346
Delta Air Lines
DAL
$56.7B
| $2.8M | 0.04% |
56,844
-249,829
| -81% | -$10.5M |
|
347
Accenture
ACN
$106B
| $2.79M | 0.04% |
31,246
+28,514
| +1,044% | +$2.37M |
|
|
CHS
348
DELISTED
Chicos FAS, Inc.
CHS
| $2.75M | 0.04% |
+169,228
| New | +$2.59M |
|
349
Boot Barn
BOOT
$4.58B
| $2.73M | 0.04% |
+149,731
| New | +$2.94M |
|
350
FedEx
FDX
$73B
| $2.68M | 0.04% |
+15,442
| New | +$2.61M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.